Pain management in patients with pancreatic carcinoma

Cancer

Volumn 78, Issue 3 SUPPL., 1996, Pages 639-653

  Caraceni, Augusto ^a   Portenoy, Russell K ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

cancer pain; oncology; palliative care; pancreatic carcinoma

Indexed keywords

CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; HUMAN; PAIN ASSESSMENT; PANCREAS CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

HUMANS; PAIN; PALLIATIVE CARE; PANCREATIC NEOPLASMS;

EID: 0029944148     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960801)78:3<639::AID-CNCR45>3.0.CO;2-X     Document Type: Review

References (141)

1. World Health Organization. Cancer pain relief and palliative care. Geneva: World Health Organization, 1990.
2. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-6.
3. Greenwald HP, Bonica JJ, Bergner M. The prevalence of pain in four cancers. Cancer 1987;60:2563-9.
4. Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage 1991;6:360-7.
5. Lillemoe KD, Cameron JL, Kaufman HS, Yeo CJ, Pitt HA, Sauter PK. Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg 1993;217:447-55.
6. Kelsen PD, Portenoy RK, Thaler HT, Niedzwiecki D, Passik D, Too Y, et al. Pain and depression in patients with newly diagnosed pancreas cancer. Clin Oncol 1995;13:748-57.
7. Singh S, Longmire W, Reber H. Surgical palliation of pancreatic cancer. Ann Surg 1990;212:132-9.
8. Costamagna G, Gabbrielli A, Mutignani M, Perri V, Crucitti F. Treatment of "obstructive" pain by endoscopic drainage in patients with pancreatic head carcinoma. Gastrointest Endose 1993;39:774-7.
9. International Association for the Study of Pain. Subcommittee on taxonomy classification of chronic pain. Pain 1986;Suppl 3:135-8.
10. Portenoy RK. Cancer pain: pathophysiology and syndromes. Lancet 1992;339:1026-31.
11. Foley KM. Pain assessment and cancer pain syndromes. In: Doyle D, Hanks GW, MacDonald N, editors. Oxford textbook of palliative medicine. Oxford: Oxford University Press, 1993:148-65.
12. Watanapa P, Williamson RC, Surgical palliation for pancreatic cancer developments during the past two decades. Br J Surg 1992;79:8-20.
13. Fontham ET, Correa P. Epidemiology of pancreatic cancer. Surg Clin North Am 1989;69(3):551-67.
14. Yeo CJ, Barry MK, Sauter PK, Sostre S, Lillemoe KD, Pitt HA, et al. Erythromycin accelerated gastric emptying after pancreaticoduodenectomy. A prospective, randomized, placebo-controlled trial. Ann Surg 1993;218:229-37.
15. Minsky BD, Hilaris B, Fuks Z. The role of radiation therapy in the control of pain from pancreatic carcinoma. J Pain Symptom Manage 1988;3:199-205.
16. Nori D, Hilaris BS, Halberg FE, Peschel RE. Pancreatic cancer: brachytherapy experience. In: Anderson LL, Chiu-Tsao S-T, Meigooni AS, Meli JA, Nath R, Nori D, Phillips TL, Smith V, Son YH, Weaver KA, editors. Interstitial brachytherapy: physical, biological, and clinical consideration. New York: Raven Press, 1990:157-64.
17. Gilly FN, Romestaing PJ, Gerard JP, Braillon GG, Sayag AC, Sentenac IJ, et al. Experience of three years with intra-operative radiation therapy using the Lyon intra-operative device. Int Surg 1990; 75:84-8.
18. Yamaue H, Tanimura H, Aoki Y, Tsunoda T, Iwahashi M, Tani M, et al. Clinical and immunological evaluation of intraoperative radiation therapy for patients with unresectable pancreatic cancer. J Surg Oncol 1992;49:10-5.
19. Boz G, De PA, Roncadin M, Franchin G, Galligioni E, Arcicasa M, et al. Radiation therapy combined with chemotherapy for inoperable pancreatic carcinoma. Tumori 1991;77:61-4.
20. Kawamura M, Kataoka M, Fujii T, Itoh H, Ishine M, Hamamoto K. Electron beam intraoperative radiation therapy (EBIORT) for localized pancreatic carcinoma. Int J Radiat Oncol Biol Phys 1992;23:751-7.
21. Kahn PJ, Skornick Y, Inbar M, Kaplan O, Chaichik S, Rozin R. Surgical palliation combined with synchronous therapy in pancreatic carcinoma. Eur J Surg Oncol 1990; 16:7-11.
22. Gazet JC, Smith R. Intra-arterial chemotherapy for patients with inoperable carcinoma of the pancreas. Proc R Soc Med 1974;67:1182-3.
23. Smith L, Gazet JC. Intraarterial-chemotherapy for patients with inoperable carcinoma of the pancreas. Ann R Coll Surg Engl 1980;62:208-12.
24. World Health Organization. Cancer pain relief. Geneva: World Health Organization, 1986.
25. Jacox A, Carr DB, Payne R, Berde CB, Breitbart W, Cain JM, et al. Management of cancer pain. Clinical practice guideline No. 9. Rockville (MD): Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1994. AHCPR Publication N 94-0592.
26. Ventafridda V, Tamburini M, Caraceni A, Deconno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987;59:851-6.
27. Takeda F. Results of field-testing in Japan of WHO Draft Interim Guidelines on Relief of Cancer Pain. The Pain Clinic 1986; 1:83-9.
28. Moertel CG, Ahman DL, Taylor WF, Schwartau N. Aspirin and pancreatic cancer pain. Gastroenterology 1971;60:552-3.
29. Loeb DS, Ahlquist DA, Talley NJ. Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs. Mayo Clin Proc 1992;67:354-64.
30. Ingham JM, Portenoy RK. Drugs in the treatment of pain: NSAIDS and Opioids. Curr Opin Anaethesiol 1993;6:838-44.
31. Kaiko RF, Foley KM, Grabinski PV, Heidrich G, Rogers A, Inturrisi CE, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13:180-5.
32. Inturrisi CE. Effects of other drugs and pathologic states on opioid disposition and response. In: Benedetti C, Chapman CR, Giron G, editors. Opioid analgesia. Recent advances in systemic administration. New York: Raven Press, 1990:171-81.
33. Ventafridda V, Ripamonti C, DeConno F. Antidepressants increase bioavailability of morphine in cancer patients [letter]. Lancet 1987;1:1204.
34. Stambaugh JE, Hemphill DM, Wainer IW, Schwartz I. A potentially toxic drug interaction between pethedine (meperidine) and phenobarbitone. Lancet 1977;1:398-9.
35. Pond SM, Kretschzma KM. Effect of phenytoin on meperidine clearance and normeperidine formation. Clin Pharmacol Ther 1981;30:680-6.
36. Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM. Rifampin-induced methadone withdrawal. N Engl J Med 1976; 294:1104-6.
37. Tong TG, Pond SM, Kreek MJ, Jaffery NF, Benowitz NL. Phenytoin-induced methadone withdrawal. Ann Intern Med 1981;94:349-51.
38. Caraceni A, Martini C, De Conno F, Ventafridda V. Organic brain syndromes and opioid administration for cancer pain. J Pain Symptom Manage 1994;9:527-33.
39. Cleeland CS. Documenting barriers to cancer pain management. In: Chapman CR, Foley KM, editors. Current and emerging issues in cancer pain: research and practice. New York: Raven Press, 1993:321-30.
40. Warncke T, Breivik H, Vainio A. Treatment of cancer pain in Norway. A questionnaire study. Pain 1994;57:109-16.
41. Cleeland CS, Cleeland LM, Dar R, Rinehardt LC. Factors influencing physician management of cancer pain. Cancer 1986;58:796-800.
42. Von Roenn JH, Cleeland CS, Gonin R, Hatfield A, Pandya JK. Physician's attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993; 119:121-6.
43. Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D, et al. Patient related barriers to management of cancer pain. Pain 1993;52:319-24.
44. Portenoy RK. Tolerance to opioid analgesics: clinical aspects. Cancer Surv 1994;21:49-65.
45. Houde RW, Wallenstein SL, Beaver WT. Evaluation of analgesics in patients with cancer pain. In: Lasagna L, editor. International Encyclopedia of pharmacology and therapeutics. Vol 1. New York: Pergamon Press, 1966:59-67.
46. Twycross RG. Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol Ther Toxicol 1974;9:184-98.
47. Kanner RM, Foley KM. Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 1981;362:161-72.
48. Porter J, Jick H. Addiction rare in patients treated with narcotics [letter]. N Engl J Med 1980;302:123.
49. Perry S, Heidrich G. Management of pain during debridement: a survey of U.S. burn unit. Pain 1982; 13:267.
50. Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain 1992;49:87-91.
51. MacDonald N, Der L, Allan S, Champion P. Opioid hyperexcitability: the application of alternate opioid therapy. Pain 1993;53:353-5.
52. Osborne RJ, Joel SP, Slevin ML. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. Brit J Med 1986;292:1548-9.
53. Ettinger DS, Vitale PJ, Trump DL. Important clinical pharmacological considerations in the use of methadone in cancer patients. Cancer Treat Rep 1979;63:457-9.
54. Plummer JL, Gourlay GK, Cherry DA, Cousins MJ. Estimation of methadone clearance: application in the management of cancer pain. Pain 1988;33:313-22.
55. Kaiko RF, Wallenstein SL, Rogers AG, Houde RW. Sources of variation in analgesic responses in cancer patients with chronic pain receiving morphine. Pain 1983;15:191-200.
56. Ventafridda V, Oliveri E, Caraceni A, Spoldi E, DeConno F, Saita L, et al. A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Manage 1987;2:77-81.
57. Portenoy RK, Moulin DE, Rogers A, Inturrisi CE, Foley KM. IV infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 1986;70:575-81.
58. Coyle N, Mauskop A, Maggard J. Continuous subcutaneous infusions of opiates in cancer patients with pain. Oncol Nurs Forum 1986;13:53-7.
59. Ventafridda V, Spoldi E, Caraceni A, Tamburini M, DeConno F. The importance of subcutaneous morphine administration for cancer pain control. The Pain Clinic 1986;1:47-55.
60. Bruera E, Brenneis C, Michaud M, Bacovsky R, Chadwick S, Emeno A, et al. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain. Cancer 1988;62:407-11.
61. Moulin DE, Kreeft JH, Murray PN, Bouquillon AI. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 1991;337:465-8.
62. Macmillan K, Bruera E, Kuehn N, Selmser P, MacMillan A. A prospective comparison study between a butterfly needle and a teflon cannula for subcutaneous narcotic administration. J Pain Symptom Manage 1994;9:82-4.
63. Citron ML, Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB. Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use. Cancer Invest 1992; 10:335-41.
64. Swanson G, Smith J, Bulich R, New P, Shiffman R. Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients. J Clin Oncol 1989; 7:1903-8.
65. Vanier MC, Labrecque G, Lepage SD, Poulin E, Provencher L, Lamontagne C. Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain: a pilot study. Pain 1993;53:27-32.
66. Storey P, Hill HH, St. Louis R, Tarver EE. Subcutaneous infusions for control of cancer symptoms. J Pain Symptom Manage 1990;5:33-41.
67. Vainio A, Tigerstedt I. Opioid treatment for radiating cancer pain: oral administration vs. epidural techniques. Acta Anaesthesiol Scand 1988;32:179-80.
68. Max MB, Inturrisi CE, Kaiko RF, Grabinski PY, Li CH, Foley KM. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clin Pharmacol Ther 1985;38:631-41.
69. Shetter AG, Hadley MN, Wilkinson E. Administration of intraspinal morphine sulphate for the treatment of incurable cancer pain. Neurosurgery 1986; 18:740-7.
70. Tanelian DL, Cousins MJ. Failure of epidural opioid to control cancer pain in a patient previously treated with massive doses of intravenous opioid. Pain 1989;36:359-62.
71. Hogan Q, Haddox JD, Abram S, Weissman D, Taylor ML, Janjan N. Epidural opiates and local anesthetics for the management of cancer pain. Pain 1991;46:271-9.
72. Du Pen S, Kharasch ED, Williams A, Peterson DG, Sloan DC, Hasche K, et al. Chronic epidural bupivacaine-opioid infusion in intractable cancer pain. Pain 1992;49:293-300.
73. Sjoberg M, Appelgren L, Einarsson S, Huttman E, Linder LE, Nitescu P, et al. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. Results from the first series of 52 patients. Acta Anaesthesiol Scand 1991; 35:30-43.
74. Waldman SD, Feldstein GS, Allen ML Troubleshooting intraspinal narcotic delivery systems. Am J Nurs 1987;87:63-4.
75. Waldman SD, Coombs DW. Selection of implantable narcotic delivery systems. Anesth Analg 1989;68:377-84.
76. Miser AW, Narang PK, Dothage JA, Young RC, Sindelar W, Miser JS. Transdermal fentanyl for pain control in patients with cancer. Pain 1989;37:15-21.
77. Simmonds MA, Richenbacher J. Transdermal fentanyl: long-term analgesic studies. J Pain Symptom Manage 1992;7(3 Suppl):S36-S9.
78. Zech DF, Grond SU, Lynch J, Dauer HG, Stollenwerk B, Lehmann KA. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients. Pain 1992; 50:293-301.
79. Portenoy RK, Southam M, Gupta SK, Lapin J, Layman M, Inturrisi CE, et al. Transdermal fentanyl for cancer pain repeated dose pharmacokinetics. Anesthesiology 1993; 78:36-43.
80. Pannuti F, Rossi AP, lafelice G, Marraro D, Camera P, Cricca A, et al. Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route. Clinical report and preliminary results on morphine pharmacokinetics. Pharmacol Res 1982; 14:369-80.
81. Bruera E, Schoeller T, Fainsinger RL, Kastelan C. Custom-made suppositories of methadone for severe cancer pain. J Pain Symptom Manage 1992;7:372-4.
82. Kaiko RF, Cronin C, Healy N, Pav J, Thomas G, Goldenheim PD. Bioavailability of rectal and oral MS-Contin [abstract]. Proc ASCO 1989;8:1307.
83. Hanning CD. The rectal absorption of opioids. In: Benedetti C, Chapman CR, Giron G, editors. Opioid analgesia. Recent advances in systemic administration. New York: Raven Press, 1990, 259-69.
84. De Conno F, Ripamonti C, Sbanotto A, Barletta L. A clinical note on sublingual buprenorphine. J Palliat Care 1993;9:44-6.
85. Stanley TH, Hague B, Mock DL, Streisand JB, Bubbers S, Dzelzkalns R, et al. Oral transmucosal fentanyl citrate (lollipop) premedications in human volunteers. Anesth Analg 1989;69:21-7.
86. Fine PG, Marcus M, DeBoer AJ, Van der Oord B. An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain. Pain 1991; 45:149-55.
87. Twycross RG, Fairfield S. Pain in far-advanced cancer. Pain 1982; 14:303-10.
88. Sykes NP. Oral naloxone in opioid associated constipation. Lancet 1991;337:1475.
89. Culpepper-Morgan JA, Inturrisi CE, Portenoy RK, Foley KM, Houde RW, Marsh F, et al. Treatment of opioid induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther 1992;52:90-5.
90. Campora E, Merlini L, Pace M, Bruzzone M, Luzzani M, Gottlieb A, et al. The incidence of narcotic-induced emesis. J Pain Symptom Manage 1991;6:428-30.
91. Bruera E, Brenneis C, Michaud M, MacDonald N. Continuous subcutaneous infusion of metoclopramide for the treatment of the narcotic bowel syndrome [letter]. Cancer Treat Rep 1987;71(11):1121-2.
92. Bruera E, Miller MJ, Macmillan K, Kuehn N. Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 1992;48:163-6.
93. Bruera E, Schoeller T, Montejo G. Organic hallucinosis in patients receiving high doses of opiates for cancer pain. Pain 1992;48:387-99.
94. Watson CPN, Evans RJ, Reed K, Merskey H, Goldsmith L, Wash J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671-3.
95. Max MB, Lynch SA, Muir J, Shoaf SE, Smollers B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1250-6.
96. Max MB, Culnane M, Schafer SC, Smoller B, Dubner R, Gracely RH. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987;37(4):589-96.
97. Watson CP, Chipman M, Reed K, Evans RJ, Birkett N. Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial. Pain 1992;48:29-36.
98. Hegarty A, Portenoy RK. Pharmacotherapy of neuropathic pain. Semin Neural 1994;14:213-24.
99. Watson CPN. Antidepressant drugs as adjuvant analgesics. J Pain Symptom Manage 1994;9:392-405.
100. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neural 1968;19:129-36.
101. Swerdlow M, Cundill JG. Anticonvulsant drugs used in the treatment of lancinating pain. A comparison. Anaesthesia 1981;36:1129-32.
102. Tanelian DL, Cousins MJ. Combined neurogenic and nociceptive pain in a patient with Pancoast tumor managed by epidural hydromorphone and oral carbamazepine. Pain 1989;36:85-8.
103. Vecht CJ, Hoff AM, Kansen PJ, de Boer MF, Bosch DA. Types and causes of pain in cancer of the head and neck. Cancer 1992;70:178-84.
104. Twycross R. Corticosteroids in advanced pain: if they are not working stop them. Brit Med J 1992;305:969-70.
105. Ettinger AB, Portenoy RK. The use of corticosteroids in the treatment of symptoms associated with cancer. J Pain Symptom Manage 1988;3:99-103.
106. Della Cuna GR, Pellegrini A, Piazzi M. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients. A placebo-control multicenter study. Eur J Cancer Clin Oncol 1989;29:1817-21.
107. Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W. Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989;7:590-7.
108. Vecht CJ, Haaxma-Reiche H, van Putten WLJ, de Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-7.
109. Popiela T, Lucchi R, Giongo F. Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 1989;25:1823-9.
110. Greenberg HS, Kim J, Posner JB. Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 1980;8:361-6.
111. Marchettini P, Lacerenza M, Marangoni C, Pellegata G, Sotgiu ML, Smime S. Lidocaine test in neuralgia Pain 1992;48:377-82.
112. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988; 1:9-11.
113. Chabal C, Jacobson L, Mariano A, Chaney E, Britell CW. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992;76:513-7.
114. Brose WG, Tanalian DL, Brodsky JB, Mark JBD, Cousins MJ. CSF and blood pharmacokinetics of hydromorphone and morphine following lumbar epidural administration. Pain 1991;45:11-7.
115. Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, DeConno F. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 1990; 76:389-93.
116. Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT. Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 1993;7:295-9.
117. Ventafridda V. Continuing care: a major issue in cancer pain management. Pain 1989;36:137-43.
118. Bridenbaugh LD, Moore DC, Campbel DD. Management of upper abdominal cancer pain. JAMA 1964; 190:877-80.
119. Singler RC. An improved technique for alcohol neurolysis of the celiac plexus. Anesthesiology 1982:56:137-41.
120. Boas RA. The sympathetic nervous system and pain relief. Monogr Anesthesiol 1983; 13:215-37.
121. Ischia SI, Luzzani A, Ischia A, Faggion S. A new approach to the neurolytic block of the celiac plexus: the transaortic technique. Pain 1983; 16:333-41.
122. Saltzburg D, Foley KM. Management of pain in pancreatic cancer. Surg Clin North Am 1989;69:629-49.
123. Ventafridda GV, Caraceni AT, Sbanotto AM, Barletta L, DeConno F. Pain treatment in cancer of the pancreas. Eur J Surg Oncol 1990; 16:1-6.
124. Mercadante S. Celiac plexus block versus analgesics in pancreatic cancer pain. Pain 1993; 52:187-92.
125. Ischia S, Ischia A, Polati E, Finco G. Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology 1992;76:534-40.
126. Fine PG, Bubela C. Chylothorax following coeliac plexus block. Anesthesiology 1985;63:654-6.
127. Thompson GE, Moore DC, Bridenbaugh LD, Artin RY. Abdominal pain and alcohol celiac plexus nerve block. Anesth Analg 1977;56:1-5.
128. Galizia EJ, Lahiri SK. Paraplegia following celiac plexus block with phenol. Br J Anaesth 1974;46:539-40.
129. Lo JN, Buckley JJ. Spinal cord ischemia: a complication of coeliac plexus block. Reg Anesth 1982;7:66-8.
130. Cherry DA, Lamberty J. Paraplegia following celiac plexus block. Anaesth Intens Care 1988;12:59-61.
131. Woodham MJ, Hanna MH. Paraplegia after celiac plexus block. Anaesthesia 1989;44:487-9.
132. Van Dongen RTM, Crul BJB. Paraplegia following celiac plexus block. Anaesthesia 1991;46:862-3.
133. Jabbal SS, Hunton J. Reversible paraplegia following coeliac plexus block. Anaesthesia 1992;47:857-8.
134. Traycoff RB, Khardori R, Zhong W. Comments on DeConno and Brown [letter to the editor]. Pain 1995;60(2):233-6.
135. Gardner AM, Solomou G. Relief of the pain of unresectable carcinoma of pancreas by chemical splanchnicectomy during laparotomy. Ann R Coll Surg Engl 1984;66:409-11.
136. Sharp KW, Stevens EJ. Improving palliation in pancreatic cancer: intraoperative celiac plexus block for pain relief. South Med J 1991;84:469-71.
137. Leger L, Mouktar M, Gontier F. Abord du splanchnique et du ganglion semilunanaire gauche par voie transperitoneale. J Chir 1964;88:489-500.
138. Dubois F. Splanchnicectomie par voie abdominale transhiatale. Press Med 1977;6:2069-70.
139. Sauvanet A, Gayet B, Flejou JF, Amaudric F, Fekete F. Role of resection of the celiac plexus in the analgesic treatment of pancreatic cancers. Ann Chir 1992;46:615-9.
140. Melki J, Riviere J, Roullee N, Soury P, Peillon C, Testart J. Splanchnicetomie thoracique sous video-thoracoscopie. Press Med 1993;22:1095-7.
141. Worsey J, Ferson PF, Keenan RJ, Julian TB, Landreneau RJ. Thoracoscopic pancreatic denervation for pain control in irresectable pancreatic cancer. Br J Surg 1993;80:1051-2.